Drug Quality and Safety Issues in India
Chokshi, Maulik; Mongia, Rahul; Wattal, Vasudha | September 2016
This document summarizes the study’s broad policy recommendations along with measures for their operationalization. Some of the major policy recommendations include uniformity in the interpretation of legal terminology contained in the relevant act and guidelines, rationalization of work distribution across regulatory personnel, use of technological tools to bridge the gap in the data available to policymakers, and need for driving the industry towards voluntary compliance and self-regulation. Participation of all stakeholders towards making dedicated efforts in these critical reform areas can pave the way for India to become a widely acknowledged source of good quality and efficacious medicines.
CitationChokshi, Maulik; Mongia, Rahul; Wattal, Vasudha. 2016. Drug Quality and Safety Issues in India. © Indian Council for Research on International Economic Relations. http://hdl.handle.net/11540/6703.
Public Health Administration
Health Care Pricing
Health Care Cost Control
Education, Health and Social Protection
Long Term Care Insurance
Public health records
Cost of medical care
Delivery of health care
Medical and health care industryShow allCollapse